The new funding brings the initiative’s total to $150 million and will focus on tau pathology, multi-marker panels, and AI-driven diagnostics.
Read More
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
Read More
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Read More
The test identifies carriers of a genetic variant found in up to 60% of Alzheimer’s patients, helping clinicians triage patients and guide treatment decisions.
Read More
The ACC, AHA, and nine other associations have issued an updated dyslipidemia guideline, recommending earlier intervention and expanded use of lipoprotein(a) and apolipoprotein B testing to improve cardiovascular risk assessment.
Read More